Physician profile
Gregory Mark Gerrish
NPI 1992097703
$634.86
in general payments reported to CMS, 2019-2025
10 companies · $268 in 2025
The $268 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $18.20 · 2021: $149 · 2023: $37.86 · 2024: $61.23 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $176.77 | 2024-2025 | Apligraf, Puraply Wound Matrix |
| Medtronic, INC. | $149.04 | 2021 | |
| Ethicon US, LLC | $92.40 | 2019-2025 | Echelon Circular, Echelon Endopath |
| Pacira Pharmaceuticals Incorporated | $45.69 | 2019 | |
| Davol INC. | $41.43 | 2023-2024 | Phasix Mesh |
| Tela Bio, INC. | $39.98 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Phathom Pharmaceuticals, INC. | $28.53 | 2024-2025 | Voquezna |
| Solventum Corporation | $25.20 | 2025 | Prevena, 3m Cavilon, Abthera |
| Molnlycke Health Care US, LLC | $19.75 | 2025 | Mepilex Border Post-Op Ag, Mepilex Border Post-Op, Mepilex |
| Smith+Nephew, INC. | $16.07 | 2023 | Stravix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Gerrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.